New Delhi [India], March 9 (ANI): British medical journal The Lancet on Tuesday published the phase 2 results of the "Made in India" COVID-19 vaccine, COVAXIN, stating that the vaccine has better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses c
Stockholm [Sweden], March 5 (ANI): Keeping an eye on the recent therapeutic antibodies discoveries that have transformed the treatment of cancer, researchers at Lund University in Sweden have developed a new, efficient method based on genetic scissors CRISPR-Cas9, that facilitates antibody d
Washington [US], February 10 (ANI): The US Food and Drug Administration (FDA) has granted an emergency use authorization to a monoclonal antibody cocktail made by pharmaceutical company Eli Lilly for treating coronavirus patients at high risk of developing severe COVID-19.
New York [US], January 28 (ANI): The tests conducted on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron's cocktail therapy can neutralize both, despite the mutations, researchers reported on Wednesday.
Washington [US], January 1 (ANI/Sputnik): US military scientists identified a miniature antibody - a nanobody - produced by a llama that appears to work well in liquid or aerosol form, suggesting it could help protect a person from the novel coronavirus, the Defense Department said in a pres
Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two experimental drugs to treat hospitalized COVID-19 patients when combined with existing treatments, said the National Institute for Allergy and Infectious Diseases (NIAID) (local time
New Delhi [India], December 7 (ANI/BusinessWire India): Taking the surging COVID-19 cases in account, 1mg.com- India's leading digital healthcare platform is gearing up to tackle the spread by providing a gamut of COVID-19 tests at home such as COVID-19 RT-PCR test, COVID antibody test as we
Washington [US], November 22 (ANI): With a new vaccine approach that would anticipate engineered immune cells from the patient's body, scientists at Scripps Research have moved closer to attaining a triumph over HIV research.
Washington [US], November 16 (ANI): The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 per cent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from th
Washington DC [US], November 10 (ANI): The US Food and Drug Administration (FDA) has approved an emergency use authorisation (EUA) for American pharmaceutical company Eli Lilly's experimental COVID-19 antibody treatment called 'bamlanivimab' for non-hospitalised patients with mild-to-moderat
Washington [US], November 4 (ANI): A new study led by investigators from Brigham and Women's Hospital examined blood samples and cells from patients who had recovered from mild to moderate COVID-19 and found that while antibodies against the virus declined in most individuals after disease r